A proposed guideline for economic evaluation of health technologies

被引:156
|
作者
Lopez Bastida, Julio [1 ]
Oliva, Juan [2 ]
Antonanzas, Fernando [3 ]
Garcia-Altes, Anna [4 ]
Gisbert, Ramon [5 ]
Mar, Javier [6 ]
Puig-Junoy, Jaume [7 ]
机构
[1] Serv Canario Salud, Unidad Planificac & Evaluac, Santa Cruz de Tenerife, Spain
[2] Univ Castilla La Mancha, Fac Ciencias Jurid & Sociales, Toledo, Spain
[3] Univ La Rioja, Dept Econ, Logrono, Spain
[4] Agencia Salut Publ Barcelona, Barcelona, Spain
[5] Univ Vic & Oblikue, Barcelona, Spain
[6] Hosp Alto Deba, Arasate, Guipuzcoa, Spain
[7] Univ Pompeu Fabra CRES, Dept Econ & Empresa, Barcelona, Spain
关键词
Economic evaluation of health care technologies; Methodology; Assessment; COST-EFFECTIVENESS ANALYSIS; ISPOR TASK-FORCE; BUDGET IMPACT ANALYSIS; QUALITY-OF-LIFE; PHARMACOECONOMIC ANALYSES; CARE; PRINCIPLES; GENERALIZABILITY; PHARMACEUTICALS; TRANSFERABILITY;
D O I
10.1016/j.gaceta.2009.07.011
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Over the last few years, economic evaluation of health technologies has become a major tool used by European health policy decision-makers to create strategies for prioritizing the allocation of health resources and the approval of new technologies. Spain was a pioneer in proposing the standardization of methodology applicable to economic evaluation studies. However, because health policy decision-makers refused to support the initiative, the methodology was never put into practice. In the medium term, evidence of the economic value of new health technologies financed by the national health system will probably be increasingly required. At that time, stakeholders and decision-makers will have to agree upon a clear and concise set of rules on the technical and methodological issues that must be followed by economic evaluations of health technologies. Consequently, we have provided guidelines and recommendations for producing first-rate economic evaluations. The recommendations appear under seventeen headings or sections. In each case, the recommended requirements to be satisfied by an economic evaluation of health technologies are provided and each recommendation is followed by a commentary, providing a justification and comparing and contrasting the proposal with other available alternatives. (C) 2009 SESPAS. Published by Elsevier Espana, S.L. All rights reserved.
引用
收藏
页码:154 / 170
页数:17
相关论文
共 50 条
  • [1] Developing the Lebanese health economic evaluation guideline
    Daccache, Caroline
    Karam, Rita
    Evers, Silvia M. A. A.
    Hiligsmann, Mickael
    Rizk, Rana
    [J]. EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2024, 24 (02) : 315 - 322
  • [2] Health Economics' and the evolution of economic evaluation of health technologies
    Hutton, John
    [J]. HEALTH ECONOMICS, 2012, 21 (01) : 13 - 18
  • [3] Economic evaluation of health technologies: challenges and perspectives
    Zerda, Alvaro
    [J]. BIOMEDICA, 2014, 34 (02):
  • [4] Decision modeling for economic evaluation of health technologies
    de Soarez, Patricia Coelho
    Soares, Marta Oliveira
    Dutilh Novaes, Hillegonda Maria
    [J]. CIENCIA & SAUDE COLETIVA, 2014, 19 (10): : 4209 - 4222
  • [5] Spanish recommendations on economic evaluation of health technologies
    Lopez-Bastida, Julio
    Oliva, Juan
    Antonanzas, Fernando
    Garcia-Altes, Anna
    Gisbert, Ramon
    Mar, Javier
    Puig-Junoy, Jaume
    [J]. EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2010, 11 (05): : 513 - 520
  • [6] Spanish recommendations on economic evaluation of health technologies
    Julio López-Bastida
    Juan Oliva
    Fernando Antoñanzas
    Anna García-Altés
    Ramón Gisbert
    Javier Mar
    Jaume Puig-Junoy
    [J]. The European Journal of Health Economics, 2010, 11 : 513 - 520
  • [7] A Framework for the health economic Evaluation of AAL Technologies
    Mahs, M.
    [J]. ZEITSCHRIFT FUR GERONTOLOGIE UND GERIATRIE, 2022, 55 (SUPPL 1): : 111 - 111
  • [8] Issues surrounding the health economic evaluation of genomic technologies
    Buchanan, James
    Wordsworth, Sarah
    Schuh, Anna
    [J]. PHARMACOGENOMICS, 2013, 14 (15) : 1833 - 1847
  • [9] ECONOMIC-EVALUATION OF HEALTH-CARE TECHNOLOGIES
    JONSSON, B
    [J]. ACTA ENDOCRINOLOGICA, 1993, 128 : 50 - 54
  • [10] A taxonomy of model structures for economic evaluation of health technologies
    Brennan, Alan
    Chick, Stephen E.
    Davies, Ruth
    [J]. HEALTH ECONOMICS, 2006, 15 (12) : 1295 - 1310